Asset Planning Services (Pennsylvania)’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-2,000
Closed -$15K – 213
2019
Q3
$15K Hold
2,000
– – 0.01% 186
2019
Q2
$15K Hold
2,000
– – 0.01% 180
2019
Q1
$16K Hold
2,000
– – 0.01% 175
2018
Q4
$15K Hold
2,000
– – 0.01% 178
2018
Q3
$14K Hold
2,000
– – 0.01% 183
2018
Q2
$13K Hold
2,000
– – 0.01% 188
2018
Q1
$13K Hold
2,000
– – 0.01% 189
2017
Q4
$15K Hold
2,000
– – 0.01% 185
2017
Q3
$14K Hold
2,000
– – 0.01% 210
2017
Q2
$17K Hold
2,000
– – 0.01% 191
2017
Q1
$16K Buy
+2,000
New +$17.3K 0.01% 198

Other funds holding RDY

Asset Planning Services (Pennsylvania)'s RDY Position: Q4 2019 in Review

Asset Planning Services (Pennsylvania) sold out of Dr. Reddy's Laboratories (RDY) in Q4 2019, closing a stake of 2,000 shares — an estimated $15K sold.

Asset Planning Services (Pennsylvania) first reported a position in RDY in Q1 2017 and held it in 11 quarters. The position peaked at $17K in Q2 2017. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Asset Planning Services (Pennsylvania) reported no remaining Dr. Reddy's Laboratories position as of Q4 2019 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 2,000 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $15K.
  • Asset Planning Services (Pennsylvania) first reported a position in Dr. Reddy's Laboratories in Q1 2017 and held it in 11 quarters.
  • Asset Planning Services (Pennsylvania)'s Dr. Reddy's Laboratories position peaked at $17K in Q2 2017.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q4 2019, filed 12 Feb 2020.